Risks
4 risks
Risk Intelligence
Integration risk from Cigniti acquisition
View Risks →Coforge Ltd — Q4 FY24
Coforge reported a strong Q4 FY24 with PAT up 94.8% YoY to INR 2,237 million, driven by robust order intake of $774 million and a record executable order book of $1.02 billion.
bullish
high
Financial stats pending filing verification
2-Minute Summary
✦ AI-Generated from Full Transcript
Coforge reported a strong Q4 FY24 with PAT up 94.8% YoY to INR 2,237 million, driven by robust order intake of $774 million and a record executable order book of $1.02 billion. Full-year organic CC revenue growth was 13.3%, meeting guidance for the fourth consecutive year. The company announced the acquisition of Cigniti Technologies, expected to create three new verticals (retail, healthcare, high tech) and expand US presence. Management guided for 50 bps EBITDA margin expansion in FY25 and targets $2 billion revenue by FY27 with 150-250 bps margin improvement from synergies. Key risk: integration challenges and potential disruption from AI in testing services.
कोफोर्ज ने चौथी तिमाही में शानदार प्रदर्शन किया। कंपनी का मुनाफा पिछले साल की तुलना में 94.8% बढ़कर 2237 करोड़ रुपये हो गया। इसकी वजह 774 मिलियन डॉलर के मजबूत ऑर्डर और 1.02 बिलियन डॉलर का रिकॉर्ड ऑर्डर बुक है। पूरे साल कंपनी की आय 13.3% बढ़ी, जो लगातार चौथी बार अपने लक्ष्य को पूरा करना है। कंपनी ने सिग्निटी टेक्नोलॉजीज को खरीदने की घोषणा की, जिससे तीन नए क्षेत्रों (खुदरा, स्वास्थ्य, हाई-टेक) में काम शुरू होगा और अमेरिका में विस्तार होगा। प्रबंधन ने अगले साल मुनाफे के मार्जिन में 0.5% सुधार का लक्ष्य रखा है और 2027 तक 2 अरब डॉलर की आय का लक्ष्य है। मुख्य जोखिम: सिग्निटी को शामिल करने में चुनौतियां और एआई से टेस्टिंग सेवाओं में बदलाव।
Risks4 trackedTranscriptfull text
Research workspace
Focused Modules
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
Order Intake (Q4)
$774M
+56% YoY
Total order intake for Q4 FY24 was $774 million, contributing to a record full-year intake of $1.97 billion.
Executable Order Book
$1.02B
+17.3% YoY
The 12-month executable order book stood at a record $1.02 billion, up from $869 million a year ago.
Utilization Rate
81.7%
+230bps QoQ
Utilization improved significantly by 230 basis points sequentially to 81.7% in Q4.
Attrition (LTM)
11.5%
-
Last twelve-month attrition fell further to 11.5%, among the lowest in the industry.
What Changed vs Last Quarter
NEW
50 bps EBITDA margin expansion in FY25
Management expects adjusted EBITDA margin to increase by approximately 50 basis points in fiscal year 2025.
NEW
Revenue growth correlated with 17.3% executable order book growth
Management pointed to the 17.3% YoY growth in the executable order book as a strong indicator of robust organic revenue growth in FY25.
NEW
Target $2 billion revenue by FY27 with 150-250 bps margin improvement
Post Cigniti acquisition, Coforge aims to become a $2 billion firm by fiscal year 2027 with operating margins improving by 150-250 basis points.
NEW
Net cash company by end of FY25
CFO Saurabh Goel stated the company endeavors to be a net cash company by the end of fiscal year 2025.
DROPPED
FY24 organic CC revenue growth to be at lower end of 13%-16% band
Management expects to deliver within the annual guidance range of 13%-16% organic constant currency revenue growth, likely near the lower end.
DROPPED
Q4 FY24 adjusted EBITDA margin to improve 150-200 bps sequentially
Q4 margins expected to rise sharply by 150-200 bps from Q3's 18%, driven by furlough reversal and new business ramp-up, targeting exit margin between 19.6% and 20.4%.
DROPPED
FY25 margins to be significantly higher than FY24
Next year margins will clearly be higher due to offshore mix improvement, SG&A peaking at 15%, and average resource cost tailwinds.
DROPPED
SG&A to remain around 15% of revenue going forward
SG&A as a percentage of revenue is expected to stay at the current 15% level, growing in line with revenue rather than as a percentage.
NEW RISK
Integration risk from Cigniti acquisition
The large acquisition may distract management and pose integration challenges, potentially impacting organic growth momentum.
NEW RISK
AI disruption in testing services
Generative AI could disrupt traditional functional testing, posing a risk to Cigniti's revenue if not proactively addressed.
NEW RISK
Client churn in Cigniti's long tail
Cigniti's client portfolio has churn in smaller accounts, which could affect revenue stability post-acquisition.
NEW RISK
Margin pressure from large deals
New large deals, especially in new accounts, come with lower initial margins, which could pressure overall profitability.
RISK GONE
Persistent pricing pressure in a competitive environment
Management acknowledged that pricing pressure remains acute and has been ongoing for five quarters, with no near-term relief expected.
RISK GONE
Flattish client budgets for CY2024 may limit growth
Budgets for calendar 2024 are not showing any significant uptick over 2023, and management is not baking in any improvement into next year's plans.
RISK GONE
Travel vertical weakness due to client-specific issues
Travel vertical grew only 3% YTD, impacted by budget cuts at a large North American client and a potential merger at another, with no clear recovery timeline.
RISK GONE
Potential deflationary impact from generative AI
An analyst raised the risk of generative AI causing deflationary pressures; management downplayed it but acknowledged the industry concern.
Fast read
Guidance and risk preview
Management expects adjusted EBITDA margin to increase by approximately 50 basis points in fiscal year 2025.
The large acquisition may distract management and pose integration challenges, potentially impacting organic growth momentum.
View Risks →